These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 12351424)

  • 1. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
    Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
    Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of troglitazone on hepatic and peripheral insulin resistance induced by growth hormone excess in rats.
    Sugimoto M; Takeda N; Nakashima K; Okumura S; Takami K; Yoshino K; Hattori J; Ishimori M; Takami R; Sasaki A; Yasuda K
    Metabolism; 1998 Jul; 47(7):783-7. PubMed ID: 9667221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.
    Willi SM; Kennedy A; Brant BP; Wallace P; Rogers NL; Garvey WT
    Diabetes Res Clin Pract; 2002 Nov; 58(2):87-96. PubMed ID: 12213349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
    Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.
    Hevener AL; Reichart D; Janez A; Olefsky J
    Diabetes; 2001 Oct; 50(10):2316-22. PubMed ID: 11574414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
    Berkowitz K; Peters R; Kjos SL; Goico J; Marroquin A; Dunn ME; Xiang A; Azen S; Buchanan TA
    Diabetes; 1996 Nov; 45(11):1572-9. PubMed ID: 8866563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
    Chen CC; Wang HJ; Shih HC; Sheen LY; Chang CT; Chen RH; Wang TY
    J Formos Med Assoc; 2001 Mar; 100(3):176-80. PubMed ID: 11393112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
    Jia DM; Tabaru A; Nakamura H; Fukumitsu KI; Akiyama T; Otsuki M
    Metabolism; 2000 Sep; 49(9):1167-75. PubMed ID: 11016899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
    Nolan JJ; Ludvik B; Beerdsen P; Joyce M; Olefsky J
    N Engl J Med; 1994 Nov; 331(18):1188-93. PubMed ID: 7935656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
    Frias JP; Yu JG; Kruszynska YT; Olefsky JM
    Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
    Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
    Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Maggs DG; Buchanan TA; Burant CF; Cline G; Gumbiner B; Hsueh WA; Inzucchi S; Kelley D; Nolan J; Olefsky JM; Polonsky KS; Silver D; Valiquett TR; Shulman GI
    Ann Intern Med; 1998 Feb; 128(3):176-85. PubMed ID: 9454525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
    Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
    Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes.
    Anil Kumar KL; Marita AR
    Br J Pharmacol; 2000 May; 130(2):351-8. PubMed ID: 10807673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
    Dea MK; Van Citters GW; Ader M; Mittelman SD; Sunehag AL; Bergman RN
    Diabetes; 2000 Dec; 49(12):2087-93. PubMed ID: 11118011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinediones exert different effects on insulin resistance between dexamethasone-treated rats and wistar fatty rats.
    Kimura M; Daimon M; Tominaga M; Manaka H; Sasaki H; Kato T
    Endocr J; 2000 Feb; 47(1):21-8. PubMed ID: 10811289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.